Global ctDNA Methylation Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global ctDNA Methylation Market Research Report 2024
ctDNA methylation refers to the analysis of DNA methylation patterns in circulating tumor DNA (ctDNA), which are fragments of DNA released into the bloodstream by tumor cells. DNA methylation is an essential epigenetic modification that involves the addition of a methyl group to the DNA molecule, typically occurring at cytosine residues within CpG dinucleotides.
According to Mr Accuracy reports new survey, global ctDNA Methylation market is projected to reach US$ 237.8 million in 2029, increasing from US$ 86 million in 2022, with the CAGR of 14.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole ctDNA Methylation market research.
Key companies engaged in the ctDNA Methylation industry include New Horizon Health Limited, genetronhealth, Burning Rock Biotech, BGI, Amoy Diagnostics Co, Singlera and Phalanx Biotech, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of ctDNA Methylation were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole ctDNA Methylation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global ctDNA Methylation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
New Horizon Health Limited
genetronhealth
Burning Rock Biotech
BGI
Amoy Diagnostics Co
Singlera
Phalanx Biotech
Segment by Type
Based on Restriction Enzyme
Based on Affinity Enrichment
Based on Bisulfite
Hospital
Third Party Organization
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The ctDNA Methylation report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports new survey, global ctDNA Methylation market is projected to reach US$ 237.8 million in 2029, increasing from US$ 86 million in 2022, with the CAGR of 14.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole ctDNA Methylation market research.
Key companies engaged in the ctDNA Methylation industry include New Horizon Health Limited, genetronhealth, Burning Rock Biotech, BGI, Amoy Diagnostics Co, Singlera and Phalanx Biotech, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of ctDNA Methylation were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole ctDNA Methylation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global ctDNA Methylation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
New Horizon Health Limited
genetronhealth
Burning Rock Biotech
BGI
Amoy Diagnostics Co
Singlera
Phalanx Biotech
Segment by Type
Based on Restriction Enzyme
Based on Affinity Enrichment
Based on Bisulfite
Segment by Application
Hospital
Third Party Organization
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The ctDNA Methylation report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source